Combination of palbociclib and radiotherapy for glioblastoma

The cyclin-dependent kinase inhibitor, palbociclib has shown compelling efficacy in breast cancer patients. Several pre-clinical studies of glioblastoma (GBM) have also shown palbociclib to be efficacious. In this study, we investigated palbociclib in combination with radiation therapy (RT) for trea...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cell Death Discov
Autors principals: Whittaker, Shane, Madani, Daniel, Joshi, Swapna, Chung, Sylvia A, Johns, Terrance, Day, Bryan, Khasraw, Mustafa, McDonald, Kerrie L
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5494656/
https://ncbi.nlm.nih.gov/pubmed/28690875
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cddiscovery.2017.33
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars